10don MSN
The Sciencewashing of Everyday Life
Fashion, beauty, and food companies are using nonsensical jargon to make a sale.
The president and his officials keep muddling their strategy.
Libevitug works by blocking hepatitis B and D viruses from entering liver cells, targeting the PreS1 domain of the viral ...
You don’t have to leave your bathroom for a salon-level experience.
The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...
Montreal Gazette on MSNOpinion
The Right Chemistry: Ripples of discovery created a new wave of weight-loss medications
When it comes to pharmacology, the big story these days is the development of the “glucagon-like peptide-1 (GLP-1) mimics,” ...
If you were anywhere near a beauty counter in 2018, you remember the \"Glass Hair\" phenomenon. It was the era of the sharp bob, the terrifyingly high h.
In Ex parte Baurin (Appeal 2024‑002920), the Patent Trial and Appeal Board (PTAB) denied the examiner’s request for rehearing and reaffirmed its ...
The global oligonucleotide CDMO market is poised for growth driven by the rising clinical pipeline of RNA-based therapies, increased mRNA therapeutic adoption, and biotech firms outsourcing to reduce ...
News Medical on MSN
New role for GLP-1 drugs: Improving survival in people with severe psychiatric disorders
By Tarun Sai Lomte An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results